Helicase Dynamics and Inhibition in SARS-CoV-2

SARS-CoV-2 helicase (nsp13) is an essential motor enzyme that unwinds double-stranded RNA during viral replication by coupling ATP hydrolysis to mechanical translocation. As a core component of the replication–transcription complex, nsp13 works in concert with the RNA-dependent RNA polymerase and accessory factors to ensure processive genome synthesis. High-resolution structural studies have revealed dynamic conformational shifts between open and closed states, coordinating substrate binding, nucleotide turnover and strand separation. These mechanistic insights have highlighted conserved pockets and regulatory interfaces as attractive targets for therapeutic intervention. Advances in biochemical assays, computational modelling and fragment-based screening have accelerated the identification of small molecules that perturb helicase activity, offering new routes to inhibit viral propagation and curb emerging variants.

Research from Nature Portfolio

Recent studies have elucidated the assembly and function of a minimal replication module comprising nsp12 polymerase and two helicase protomers. Cryo-electron microscopy captured two distinct conformers in which one helicase monomer stabilises the RNA duplex and the other modulates polymerase–helicase contacts, clarifying how conformational shifts enhance strand separation. Complementary crystallographic analyses of nsp13 in apo and ATP-analog-bound forms uncovered two highly conserved druggable cavities. A systematic fragment screen against these sites yielded a diverse set of chemical starting points for structure-guided inhibitor design, mapping interaction hot spots and revealing allosteric mechanisms. These combined structural efforts establish a robust framework for rational development of helicase antagonists.

Helicase Dynamics and Inhibition in SARS-CoV-2 publication trend

The graph below shows the total number of articles in helicase dynamics and inhibition in sars-cov-2 across all publications each year (not limited to Nature Index journals).

Technical terms

Helicase: An enzyme that utilises the energy of ATP hydrolysis to unwind duplex nucleic acids, essential for viral genome replication.

Replication–transcription complex: A multi-protein assembly including polymerase and helicase subunits that orchestrates RNA synthesis in coronaviruses.

ATPase activity: The catalytic function by which an enzyme hydrolyses ATP to ADP and inorganic phosphate, driving conformational changes.

Fragment screening: A structural biology approach that tests low-molecular-weight compounds for binding to target sites, guiding hit-to-lead development.

Molecular docking: A computational method that predicts the preferred orientation and binding affinity of small molecules within a protein’s active or allosteric site.

References

1. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance. mBio (2023).
2. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity. International Journal of Molecular Sciences (2023).
3. Architecture of a SARS-CoV-2 mini replication and transcription complex. Nature Communications (2020).
4. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase. Nature Communications (2021).
5. Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry (2022).